JWJoshua Wang

Joshua Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joshua Wang has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact of preoperative osteoporosis on short- and long-term complications following ankle ORIF: A multi-institutional propensity-matched analysis

    by Keenan Horani, Jad Lawand, Joshua Wang, Nicholas Cione, Abdullah Ghali, Verdinand C.B. Ruelos, John C. Hagedorn

  • Radiation‐Induced Skin Toxicity Risk in Breast Cancer Patients With Atopic or Allergic Conditions

    by Philong Nguyen, Julia Ding, Joshua Wang, Yena Jang, Joshua Borja, Gabriela Villa, Tiffany Cheng, Yousef Tanas, Wei‐Chen Lee

    Summary: Atopy increases both acute and long‐term radiation skin toxicity risk. Elevated dermatologic morbidity persists through 36 months post‐radiotherapy.

  • Overweight and premorbid obesity status correlates with thromboembolism risk but not infection after total shoulder arthroplasty

    by Joshua Wang, Philong Nguyen, Kerollos Ibrahim, Yousef Tanas, Carolyn Henein, Joshua Borja, Keenan Horani, Jeremy Somerson, William M. Weiss

  • Open Access

    Septated gallbladder: a rare congenital anomaly and its clinical implications

    by Sudhanvan Iyer, Philong Nguyen, Joshua Wang, Suimin Qiu, Cristiana Rastellini, Luca Cicalese

    A septated gallbladder (SG) is a rare anatomical variant characterized by the presence of one or more fibrous or muscular septa dividing the lumen into multiple chambers. While an acquired form of septation has been discussed, most reported cases are treated as congenital variants. This study presents a case of SG identified during clinical evaluation and discusses its clinical significance. The patient is a 64-year-old woman with a history of right upper quadrant (RUQ) abdominal pain that radiates to the right scapula. She reports pain beginning 10 years ago as intermittent episodes but has progressed over the past two months. Upon review of prior imaging studies, a SG was identified, and the patient was scheduled for a laparoscopic cholecystectomy. The presence of septa was confirmed intraoperatively. Following the procedure, her symptoms resolved completely. Awareness of SG is essential for clinicians and radiologists to prevent misdiagnosis and guide appropriate management. While incidental, symptomatic cases benefit from surgical intervention.

  • Preoperative Proton Pump Inhibitor Use Was Associated With Increased Risk of Revision Surgery and Impaired Bone Healing Following Pelvic Fracture Fixation: A Retrospective Cohort Study

    by Joshua Wang, Emmerson McGowan, Keenan Horani, John C. Hagedorn

    OBJECTIVES: To evaluate the association between preoperative proton pump inhibitor (PPI) use and postoperative outcomes following pelvic fracture fixation. METHODS: Design: Retrospective cohort study. Setting: TriNetX Research Network, a federated database of electronic medical records from approximately 103 healthcare organizations. Patient Selection Criteria: Adult patients aged 18 years and older who underwent surgical fixation of pelvic fractures between 2000 and 2023 were identified. All operatively managed pelvic fracture types were included, encompassing OTA/AO classifications 61A–C; however, specific fracture classification was not available within the database. Patients were stratified into cohorts based on preoperative PPI use. Outcome Measures and Comparisons: Postoperative outcomes, including sepsis, revision surgery, hardware removal, nonunion, and malunion, were compared between patients with and without preoperative PPI use at 90 days and 2 years following surgery. RESULTS: Before matching, 2,648 patients were included in the preoperative PPI cohort and 7,655 patients in the control cohort. After propensity score matching, 2,403 patients remained in each cohort. The mean age was 44.0 ± 17.3 years in the PPI cohort and 43.7 ± 17.0 years in the control cohort, with 37.3% and 38.6% female patients, respectively. At 90 days postoperatively, preoperative PPI use was associated with increased risks of sepsis (RR 1.48, 95% CI 1.07–2.06, p=0.017), deep vein thrombosis (RR 1.58, 95% CI 1.11–2.23, p=0.010), revision surgery (RR 1.69, 95% CI 1.28–2.22, p<0.001), and hardware removal (RR 1.58, 95% CI 1.20–2.08, p<0.001). At 2 years, preoperative PPI use remained associated with increased risk of revision surgery (RR 1.66, 95% CI 1.27–2.15, p<0.001), as well as nonunion (RR 1.71, 95% CI 1.10–2.65, p=0.015) and hardware removal (RR 1.17, 95% CI 1.01–1.36, p=0.039). No other significant differences were observed. CONCLUSIONS: Preoperative PPI use was associated with increased risks of both short-term complications and long-term adverse outcomes following pelvic fracture fixation, including higher rates of sepsis, nonunion, malunion, and revision surgery. Level of Evidence: Level III, Prognostic


  • Geographic Distribution and Drive Times to Glaucoma Specialists in the United States

    by Joshua Wang, Jean Adomfeh, Agnes C. Owete, Shivani Kamat, Mary Qiu, Kelly W. Muir

  • The Impact of Preoperative Activity on Postoperative Outcomes in Total Knee Arthroplasty: A Retrospective Cohort Analysis

    by Joshua S. Wang, Gyan M. Narayan, Varun M. Trivedi, Ashwin A. Vivekananthan, Keenan Horani, William M. Weiss

  • Impact of Nicotine Dependence on Postoperative Outcomes in Pilon Fracture Open Reduction and Internal Fixation: A Comparative Cohort Analysis

    by Joshua Wang, Brandon N. Cambre, Daniel H. Cho, Annie L. M. Dugan, Vishank Panchbhavi, Allen S. Wang, Vinod K. Panchbhavi

    OBJECTIVES: To examine postoperative complication rates in patients with nicotine dependence compared with nonusers to clarify the risks in pilon fracture recovery. METHODS: Design: Retrospective cohort analysis. Setting: Data from the TriNetX Health Research Network. Patient Selection Criteria: Patients aged 18 years or older who underwent open reduction internal fixation (ORIF) for OTA/AO type 43 pilon fractures between 2000 and 2022 were categorized into nicotine-dependent and nondependent groups. Outcome Measures and Comparisons: Primary outcomes included rates of malunion, nonunion, mechanical complications such as internal fixation failure or removal, and need for revision surgery by 2-year follow-up. Secondary outcomes over a 90-day period included wound disruption, infection, sepsis, and thrombotic events. Statistical analysis calculated risk ratios and odds ratios, with significance set at P < 0.05. RESULTS: After propensity score matching (N = 4371 patients in each cohort), the mean age was 44.4 ± 14.5 years in cohort 1 and 44.7 ± 15.7 years in cohort 2. Female patients comprised 34.9% of cohort 1% and 35.3% of cohort 2. Nicotine dependence was associated with increased risks of mechanical complications (5.8% vs. 4.4%; P = 0.003), malunion/nonunion (6.3% vs. 4.7%; P = 0.002), wound disruption (4.5% vs. 3.2%; P = 0.002), and a higher infection rate (5.7% vs. 3.7%; P < 0.001). Conversely, the incidence of pulmonary embolism was lower in nicotine users (0.3% vs. 0.7%; P = 0.005). CONCLUSIONS: Nicotine dependence showed significantly elevated risk of adverse postoperative outcomes in pilon fracture surgeries, including mechanical failure, wound complications, and infection. However, the incidence of pulmonary embolism was lower among nicotine users. These results underscored an association between preoperative nicotine dependence and postoperative complications. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Vitamin D Deficiency as a Risk Factor for Hypertrophic Scarring and Reconstructive Surgeries After Burns

    by Philong Nguyen, Joshua Wang, Yousef Tanas, Haidara Bohsas, Alexandra Dunker, Kamryn K Baker, Kevin Vargas, Sudhanvan Iyer, Carolyn Henein, Cameron Bowers, et al.

    Background: Vitamin D plays an important role in immune regulation, collagen remodeling, and wound healing. In the general population, deficiency has been associated with poor wound repair and fibrosis, yet evidence in burn patients remains limited. Burn injuries often result in hypertrophic scarring and significant healthcare utilization for reconstructive and adjunctive procedures. Objectives: This study examines the impact of preexisting vitamin D deficiency on hypertrophic scarring and scar-related healthcare utilization in a large, multi-institutional cohort of burn patients. Methods: The TriNetX Research Network was queried for patients ≥18 years old with burn injuries between 2010 and 2023. Patients with vitamin D deficiency, defined as 25-hydroxyvitamin D <20 ng/mL within 1 month before injury, were matched 1:1 to nondeficient controls using propensity score matching. Matching variables included demographics, BMI, comorbidities, substance use, vitamin deficiencies (A, C, E, and K), calcidiol levels, and total burn surface area. The primary outcome was hypertrophic scarring. Secondary outcomes included scar-related interventions: Z-plasty and intralesional corticosteroid injections. Cumulative incidence was assessed at 3, 12, and 24 months. Hazard ratios (HRs) with 95% CIs were calculated using Cox proportional hazards models. Results: After matching, 6832 patients were included in each cohort. Vitamin D deficiency was associated with significantly higher rates of hypertrophic scarring at 3 months (5.82% vs 2.55%, HR 2.33, 95% CI, 1.93-2.81, P < .0001), 12 months (9.38% vs 4.56%, HR 2.12, 95% CI, 1.84-2.46, P < .0001), and 24 months (10.61% vs 5.26%, HR 2.09, 95% CI, 1.83-2.40, P < .0001). Vitamin D–deficient patients also demonstrated greater use of reconstructive procedures, including Z-plasty (HR 1.86-2.38) and corticosteroid injection (HR 3.14-3.56). Conclusions: Vitamin D deficiency is strongly associated with increased hypertrophic scarring and greater reliance on reconstructive and adjunctive procedures following burn injury. These results underscore the potential role of micronutrient status in long-term burn recovery. Prospective studies are needed to determine whether early detection and correction of deficiency can mitigate scarring and reduce healthcare utilization. Level of Evidence: 3 (Risk): For image description, please refer to the figure legend and surrounding text.

  • Open Access

    Long-Term Outcomes of Preoperative Botulinum Toxin Use in Abdominal Wall Reconstruction: A Propensity-Matched Analysis of More Than 5000 Patients Over 5 Years

    by Yousef Tanas, Stephen Chen, Philong Nguyen, Joshua Wang, Haidara Bohsas, Dora Lena Fedorcsak, Tue Dinh

    Background: Preoperative botulinum toxin (BTX) has been proposed to facilitate myofascial medialization and tension reduction in abdominal wall reconstruction (AWR), but long-term comparative outcomes are unclear. Objectives: To compare short- and long-term postoperative outcomes after AWR in patients receiving preoperative BTX vs no BTX. Methods: We performed a retrospective cohort study using the TriNetX National Health Research Network. Adults undergoing AWR were identified by ICD-10/CPT codes and assigned to BTX or no-BTX cohorts. Propensity score matching (1:1) balanced demographics, comorbidities, related procedures, and medications at each follow-up point. Outcomes included hernia recurrence, infections, wound disruption, seroma, hematoma, surgical site infection (SSI), and reoperation, assessed at 6 months, 1, 3, and 5 years. Results: At 6 months, BTX was associated with lower hernia recurrence (32.1% vs 35.6%; P = .013) but higher risks of infections (14.4% vs 10.5%; P < .001), wound disruption (8.7% vs 4.7%; P < .001), hematoma (1.3% vs 0.5%; P = .003), SSI (3.9% vs 2.4%; P = .002), and reoperation (10.7% vs 7.8%; P = .001). From 1 to 5 years, recurrence rates no longer differed significantly between groups (eg, 5 years: 42.6% vs 44.8%; P = .112). The BTX cohort continued to demonstrate higher rates of infections, wound disruption, hematoma, SSI, and reoperation across later time points (all P < .05). Conclusions: Preoperative BTX for AWR was linked to an early reduction in recurrence but higher postoperative complications and reoperation over time. These observational data highlight the need for standardized BTX protocols and prospective trials to define patient selection and to balance potential short-term mechanical benefits against complication risks. Level of Evidence: 3 (Risk):